Dipòsit Digital de Documents de la UAB 3 registres trobats  La cerca s'ha fet en 0.00 segons. 
1.
14 p, 455.4 KB Cost Analysis of FreeStyle Libre ® 2 System in Type 2 Diabetes Mellitus Population / Oyagüez, Itziar (Pharmacoeconomics and Outcomes Research Iberia (PORIB)) ; Gómez-Peralta, Fernando (Hospital General de Segovia) ; Artola, Sara (Centro de Salud José Marvá, Madrid) ; Carrasco Trancoso, Francisco Javier (Universitat de Girona) ; Carretero-Gómez, Juana (Hospital de Zafra, Badajoz) ; García-Soidan, Javier (Centro de Saúde do Porriño) ; Gomez Huelgas, Ricardo (Hospital Regional Universitario de Málaga) ; Merino-Torres, Juan F. (Hospital Universitari i Politècnic La Fe (València)) ; Pérez Pérez, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
FreeStyle Libre ® 2 system is a sensor-based flash-monitoring system that measures interstitial fluid glucose. The study aimed to compare cost of FreeStyle Libre 2 system and self-monitoring of blood glucose (SMBG) in the type 2 diabetes mellitus (T2DM) population from the Spanish Health System perspective. [...]
2021 - 10.1007/s13300-021-01064-4
Diabetes Therapy, may 2021, p. 1-14  
2.
2 p, 175.3 KB Correction to : Cost Analysis of FreeStyle Libre ® 2 System in Type 2 Diabetes Mellitus Population / Oyagüez, Itziar (Pharmacoeconomics and Outcomes Research Iberia (PORIB), Paseo Joaquín Rodrigo 4 - letra I, Pozuelo de Alarcón, 28224 Madrid, Spain) ; Gómez-Peralta, Fernando (Hospital General de Segovia) ; Artola, Sara (Centro de Salud José Marvá, Madrid) ; Carrasco Trancoso, Francisco Javier (Hospital Juan Ramón Jiménez (Huelva)) ; Carretero-Gómez, Juana (Hospital de Zafra, Badajoz) ; García-Soidan, Javier (Servicio atención primaria de o Porriño) ; Gomez Huelgas, Ricardo (Hospital Regional Universitario de Málaga) ; Merino-Torres, Juan F. (Hospital Universitari i Politècnic La Fe (València)) ; Pérez Pérez, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
2021 - 10.1007/s13300-021-01093-z
Diabetes Therapy, Vol. 12 (july 2021) , p. 2263-2264  
3.
13 p, 347.6 KB Prediction of week 4 virological response in hepatitis C for making decision on triple therapy : the Optim study / Romero-Gómez, Manuel (Hospital Universitario Virgen de Valme (Sevilla, Andalusia)) ; Turnes, Juan (Complejo Hospitalario Universitario de Pontevedra) ; Ampuero, Javier (Hospital Universitario Virgen de Valme (Sevilla, Andalusia)) ; Oyagüez, Itziar (Pharmacoeconomics & Outcomes Research IBeria (Madrid)) ; Cuenca, Beatriz (Hospital Universitario Infanta Cristina) ; Gonzalez-García, Juan (Hospital Universitario La Paz (Madrid)) ; Muñoz-Molina, Belén (Roche Farma) ; Aguilar, Rocío (Fisevi (Sevilla)) ; Leal, Sandra (Fisevi (Sevilla)) ; Planas Vilà, Ramon (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Garcia-Samaniego, Javier (Hospital Carlos III (Madrid)) ; Diago, Moises (Hospital General Universitario de Valencia) ; Crespo García, Javier (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Calleja, Jose Luis (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Casado, Miguel Ángel (Pharmacoeconomics & Outcomes Research IBeria (Madrid)) ; Solà Lamoglia, Ricard (Hospital del Mar (Barcelona, Catalunya))
Background: Virological response to peginterferon + ribavirin (P+R) at week 4 can predict sustained virological response (SVR). While patients with rapid virological response (RVR) do not require triple therapy, patients with a decline <1log10 IU/ml HCVRNA (D1L) should have treatment discontinued due to low SVR rate. [...]
2015 - 10.1371/journal.pone.0122613
PloS one, Vol. 10, No 3 (March 2015) , p. e0122613  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.